Kelun Pharmaceutical: Intends to purchase 99.42% equity of Hongjitang

Jinshi data, December 20 news, KeYuan Pharmaceutical announced that the company intends to issue shares to Linuo Investment Holding Group Co., Ltd., Linuo Group Co., Ltd., and 39 other transaction parties, and purchase 99.42% equity of Shandong Hongjitang Pharmaceutical Group Co., Ltd. held by them in cash. At the same time, the company intends to issue shares to raise matching funds for not more than 35 specific objects. This transaction constitutes a related party transaction, a major asset restructuring but not a restructuring for listing. As of the date of this announcement, due diligence, audit, evaluation, or valuation related to this transaction are in progress.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)